23:54 , Jun 14, 2019 |  BC Extra  |  Politics & Policy

June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more

Washington follows Louisiana in creating 'Netflix' model to buy HCV drugs  CMS approved Washington's Medicaid state plan amendment proposal to establish a subscription-based model for HCV drugs, under which the state would pay a fixed...
23:38 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data. As a...
00:33 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

Senators call for HHS probe into CMS genetic testing payments to Chinese-linked companies

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....
21:33 , May 13, 2019 |  BC Extra  |  Financial News

MGI Tech raises $200M for high throughput gene sequencers

Sequencing technology company MGI Tech raised over $200 million in an undisclosed financing backed by CITIC Goldstone Capital, Green Pine Capital Partners and Orient Securities Capital Investment. MGI Tech Co. Ltd. said it plans to...
16:38 , Aug 18, 2017 |  BC Extra  |  Preclinical News

Papers describe liquid biopsy next-generation sequencing

At least five recently published studies have shown the utility of liquid-based biopsies in cancer detection, suggesting that liquid biopsy next-generation sequencing (NGS) could replace traditional detection methods of PCR and tumor biopsies. In addition,...
00:18 , Aug 18, 2017 |  BC Innovations  |  Translation in Brief

Next-generation growth spurt

A milestone FDA approval could signal next-generation sequencing tests are on the verge of becoming established players in cancer diagnostics. A series of papers published this week highlights further advances in NGS technology, but the...
23:24 , Aug 3, 2017 |  BC Innovations  |  Tools & Techniques

The other side of the Rubicon

In the end, it might be the efficacy that guides the ethics. By showing that editing of human embryos using CRISPR can be performed efficiently and without leading to the much-feared slew of off-target cuts,...
17:19 , Aug 2, 2017 |  BC Extra  |  Preclinical News

U.S. researchers buck embryo editing guidelines

In direct contravention of the position against germline gene editing taken by NIH, a team led by scientists from Oregon Health & Science University published a study in Nature on Wednesday detailing CRISPR-Cas9-mediated gene correction...
07:00 , May 5, 2014 |  BioCentury  |  Politics, Policy & Law

Clarion call from Congress

While a great deal of political energy in Washington continues to be directed to partisan battles over Obamacare, the House Energy & Commerce Committee has found time to lay the foundations for a bipartisan effort...
01:30 , Feb 26, 2014 |  BC Extra  |  Financial News

BGI subsidiary planning IPO

Sequencing company BGI (Shenzhen, China) said it is "working on" an IPO, but declined to disclose details. According to several media outlets, BGI's BGI Tech Solutions Co. Ltd. subsidiary is seeking to list in Hong...